For: | Lai SC, Loh EW, Chiou DI, Hong CT. Efficacy and safety of anti-vascular endothelial growth factor agents on corneal neovascularization: A meta-analysis. World J Clin Cases 2023; 11(30): 7337-7349 [PMID: 37969435 DOI: 10.12998/wjcc.v11.i30.7337] |
---|---|
URL: | https://www.wjgnet.com/2307-8960/full/v11/i30/7337.htm |
Number | Citing Articles |
1 |
Jingjuan Zhang, Yongjun Qi, Yongzheng Li, Furong Zhu, Yizhuo Geng, Yu Li, Bai Xue, Hongzheng Bi, Ya Jiao, Huan Min, Duyin Jiang, Guangjun Nie, Yingqiu Qi. PROTAC based targeted degradation of LRG1 for mitigating corneal neovascularization. Journal of Controlled Release 2025; 381: 113567 doi: 10.1016/j.jconrel.2025.02.063
|
2 |
Elsie Chan, Jennifer Fan Gaskin, Elsa C. Chan. Corneal Neovascularisation and Anti-VEGF Therapy. Targets 2025; 3(1): 9 doi: 10.3390/targets3010009
|
3 |
Muna Salim Al-Ruhaili, Haitham Hilal Al-Mahrouqi. Corneal melting following intrastromal injection of bevacizumab for corneal neovascularization. Oman Journal of Ophthalmology 2025; 18(2): 205 doi: 10.4103/ojo.ojo_344_24
|
4 |
Yizhuo Geng, Jingjuan Zhang, Shiyu Song, Maoheng Xie, Hongzheng Bi, Huan Min, Jian Song, Yingqiu Qi. Inorganic nanomaterials as promising therapeutic agents for ocular neovascularization: Progress and perspectives. Materials Today Bio 2025; 33: 102051 doi: 10.1016/j.mtbio.2025.102051
|